1. The financial conflicts of interest involved in these commentaries were not with tobacco companies, but with pharmaceutical companies. Every instance where "tobacco company" appears should be replaced with "pharmaceutical company," and "Big Tobacco" should be replaced with "Big Pharma." The article errantly refers to R.J. Reynolds, Lorillard, Brown & Williamson, Star Scientific, U.S. Tobacco, Liggett, and Santa Fe Natural Tobacco Company. These companies should have been listed as Elan Pharmaceutical, SmithKline Beecham, Glaxo Wellcome, GlaxoSmithKline, Nabi Biopharmaceuticals, Pfizer, Sanofi-Synthelabo, sanofi-aventis, Lederle, Ciba-Geigy, McNeil Consumer Products, and Pharmacia. We apologize for any inconvenience these errors may have caused.

2. In contrast to what we reported above, the anti-smoking groups have not - I repeat, have not - criticized the researchers for failing to disclose their conflicts of interest. They did not argue that "section 5 of the form refers to any and all conflicts of interest, regardless of when they occurred," and that "these researchers are breaking not only the spirit, but also the letter of these policies." We apologize for having incorrectly insinuated that these anti-smoking groups are concerned about the scientific and ethical integrity of published tobacco control research.

LAST：New Popular Healthy E Cigarette with eGo WCE3 atomizer |NEXT：fashionable design ecig vaped glass globe clearomizer best selling in EU and USA